CIAM
TEVA icon

Caitong International Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Caitong International Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.1K Buy
+2,099
New +$69.9K 0.01% 635
2026
Q1 		– Sell
-619
Closed -$19.3K – 3038
2025
Q4 		$19.3K Buy
619
+419
+210% +$10.3K ﹤0.01% 1000
2025
Q3 		$4.04K Sell
200
-276
-58% -$4.85K ﹤0.01% 1273
2025
Q2 		$7.98K Sell
476
-5,367
-92% -$86.6K 0.01% 823
2025
Q1 		$89.8K Sell
5,843
-6,787
-54% -$121K 0.07% 314
2024
Q4 		$278K Buy
+12,630
New +$230K 0.27% 54

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Caitong International Asset Management's TEVA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 2,099 shares worth $71.1K. The stake represents 0.01% of the portfolio and ranks #635 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in TEVA as recently as Q4 2025.

Caitong International Asset Management first reported a position in TEVA in Q4 2024 and has held it in 6 quarters since. The position peaked at $278K in Q4 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Caitong International Asset Management held 2,099 shares of Teva Pharmaceuticals worth $71.1K as of Q2 2026.
  • Teva Pharmaceuticals was a new Caitong International Asset Management position in Q2 2026.
  • Teva Pharmaceuticals made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #635 holding.
  • Caitong International Asset Management first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Teva Pharmaceuticals position peaked at $278K in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.